Marsh Q2 revenue +6%; operating income -5% YTD on $425M Greensill litigation charge

Filed July 21, 2026 · Period ending June 30, 2026 · Compared to 10-Q Jul 17, 2025 · ~1 min read

Key Changes

• high

  Recorded $425M liability in Q1 2026 for Greensill litigation in Australia, including settlement with Greensill Bank and estimate for remaining Credit Suisse claims; trial scheduled September 2026.

  Notes: Greensill litigation liability verify on EDGAR →
• high

  Accelerated share buybacks to $1.5B in H1 2026 (8.7M shares) vs $600M prior year under new $6B authorization; $4.2B remains available.

  MD&A: Share repurchase authorization verify on EDGAR →
• high

  Launched three-year Thrive restructuring program targeting $500M in costs and $400M annualized savings; incurred $239M through Q2 2026, primarily severance.

  MD&A: Thrive restructuring program verify on EDGAR →